memantine has been researched along with Cholera Infantum in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Three head-to-head trials of ChEIs in the treatment of AD have been published to date, but are limited due to their open-label design, rates of titration, and the drug dosage levels utilised." | 2.42 | The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. ( Herrmann, N; Lanctôt, KL; Thompson, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bures, J | 1 |
| Kvetina, J | 1 |
| Radochova, V | 1 |
| Tacheci, I | 1 |
| Peterova, E | 1 |
| Herman, D | 1 |
| Dolezal, R | 1 |
| Kopacova, M | 1 |
| Rejchrt, S | 1 |
| Douda, T | 1 |
| Sestak, V | 1 |
| Douda, L | 1 |
| Karasova, JZ | 1 |
| Thompson, S | 1 |
| Lanctôt, KL | 1 |
| Herrmann, N | 1 |
1 review available for memantine and Cholera Infantum
| Article | Year |
|---|---|
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseas | 2004 |
1 other study available for memantine and Cholera Infantum
| Article | Year |
|---|---|
The pharmacokinetic parameters and the effect of a single and repeated doses of memantine on gastric myoelectric activity in experimental pigs.
Topics: Administration, Oral; Alzheimer Disease; Animals; Disease Models, Animal; Electromyography; Excitato | 2020 |